Subscribe to RSS
DOI: 10.1055/a-2422-9363
Evaluating endoscopic ultrasound-guided tissue acquisition for diagnosis of small pancreatic neuroendocrine neoplasms
Abstract
Background and study aims Although small hypervascular tumors are suspected to be pancreatic neuroendocrine tumors (p-NENs), their diagnosis and treatment are challenging. This study evaluated the usefulness of endoscopic ultrasound-guided tissue acquisition (EUS-TA) for diagnosis of small p-NENs.
Methods All p-NEN lesions that underwent EUS-TA at our hospital between April 2018 and December 2023 were retrospectively analyzed. The diagnostic sensitivity of EUS-TA and the concordance rate of grading with EUS-TA and surgical specimens were examined. The lesions were grouped by size.
Results The diagnostic sensitivity of EUS-TA was analyzed for 82 lesions, of which 44 were compared with postoperative specimens for grading. The definitive diagnosis was neuroendocrine tumor (NET) in 75 lesions, neuroendocrine carcinoma in five lesions, and mixed neuroendocrine non-neuroendocrine neoplasm in two lesions. Thirty tumors were ≤10 mm, 30 were 10 to 20 mm, and 22 were >20 mm, and the diagnostic sensitivities were 96.7%, 96.7%, and 90.9%, respectively. Concordance rates for grading were 94.4%, 82.4%, and 77.8% for tumors ≤10 mm, 10 to 20 mm, and ≥20 mm, respectively, with Cohen’s kappa coefficients of 0.64, 0.48, and 0.40, respectively.
Conclusions EUS-TA showed adequate diagnostic sensitivity and grading agreement for p-NENs of all sizes, allowing for determination of appropriate treatment.
Publication History
Received: 11 July 2024
Accepted after revision: 26 September 2024
Accepted Manuscript online:
07 October 2024
Article published online:
28 November 2024
© 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).
Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
-
References
- 1 Fesinmeyer MD, Austin MA, Li CI. et al. Differences in survival by histologic type of pancreatic cancer. Cancer Epidemiol Biomarkers Prev 2005; 14: 1766-1773
- 2 Gill AJ, Klimstra DS, Lam AK. WHO Classification of Tumours Editorial Board. et al. Neuroendocrine neoplasms. In: WHO Classification of Tumours- Digestive System Tumours. Lyon: IARC Press; 2019: 343-370
- 3 Garcia-Carbonero R, Sorbye H, Baudin E. et al. ENETS consensus guidelines for high-grade gastroenteropancreatic neuroendocrine tumors and neuroendocrine carcinomas. Neuroendocrinology 2016; 103: 186-194
- 4 Wang F, Lou X, Qin Y. et al. Mixed neuroendocrine nonneuroendocrine neoplasms of the pancreas: a case report and literature review of pancreatic mixed neuroendocrine nonneuroendocrine neoplasm. Gland Surg 2021; 10: 3443-3452
- 5 Falconi M, Eriksson B, Kaltsas G. et al. ENETS consensus guidelines update for the management of patients with functional pancreatic neuroendocrine tumors and non-functional pancreatic neuroendocrine tumors. Neuroendocrinology 2016; 103: 153-171
- 6 Yao JC, Hassan M, Phan A. et al. One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol 2008; 26: 3063-3072
- 7 Halfdanarson TR, Rubin J, Farnell MB. et al. Pancreatic endocrine neoplasms: epidemiology and prognosis of pancreatic endocrine tumors. Endocr Relat Cancer 2008; 15: 409-427
- 8 Hallet J, Law CHL, Cukier M. et al. Exploring the rising incidence of neuroendocrine tumors: a population-based analysis of epidemiology, metastatic presentation, and outcomes. Cancer 2015; 121: 589-597
- 9 Jutric Z, Grendar J, Hoen HM. et al. Regional metastatic behavior of nonfunctional pancreatic neuroendocrine tumors: impact of lymph node positivity on survival. Pancreas 2017; 46: 898-903
- 10 Pan M, Yang Y, Teng T. et al. Development and validation of a simple-to-use nomogram to predict liver metastasis in patients with pancreatic neuroendocrine neoplasms: a large cohort study. BMC Gastroenterol 2021; 21: 101
- 11 Gratian L, Pura J, Dinan M. et al. Impact of extent of surgery on survival in patients with small non-functional pancreatic neuroendocrine tumors in the United States. Ann Surg Oncol 2014; 21: 3515-3521
- 12 Lloyd RV, Osamura RY, Klöppel GN. et al. WHO Classification of Tumours of Endocrine Organs. Lyon, France: WHO; 2017
- 13 Javed AA, Pulvirenti A, Zheng J. et al. A novel tool to predict nodal metastasis in small pancreatic neuroendocrine tumors: A multicenter study. Surgery 2022; 172: 1800-1806
- 14 Levine I, Trindade AJ. Endoscopic ultrasound fine needle aspiration vs fine needle biopsy for pancreatic masses, subepithelial lesions, and lymph nodes. World J Gastroenterol 2021; 27: 4194-4207
- 15 Eusebi LH, Thorburn D, Toumpanakis C. et al. Endoscopic ultrasound-guided fine-needle aspiration vs fine-needle biopsy for the diagnosis of pancreatic neuroendocrine tumors. Endosc Int Open 2019; 7: E1393-E1399
- 16 Witt BL, Factor RE, Chadwick BE. et al. Evaluation of the SharkCore needle for EUS-guided core biopsy of pancreatic neuroendocrine tumors. Endosc Ultrasound 2018; 7: 323-328
- 17 Di Leo M, Poliani L, Rahal D. et al. Pancreatic neuroendocrine tumours: the role of endoscopic ultrasound biopsy in diagnosis and grading based on the WHO 2017 classification. Dig Dis 2019; 37: 325-333
- 18 Kamata K, Ashida R, Yasukawa S. et al. Histological diagnosis and grading of pancreatic neuroendocrine tumor by endoscopic ultrasound-guided fine needle biopsy using a 25-gauge needle with a core trap: A multicenter prospective trial. Pancreatology 2020; 20: 1428-1433
- 19 Hijioka S, Hara K, Mizuno N. et al. Diagnostic performance and factors influencing the accuracy of EUS-FNA of pancreatic neuroendocrine neoplasms. J Gastroenterol 2016; 51: 923-930
- 20 Ishii T, Katanuma A, Toyonaga H. et al. Role of endoscopic ultrasound in the diagnosis of pancreatic neuroendocrine neoplasms. Diagnostics 2021; 11: 316
- 21 Unno J, Kanno A, Masamune A. et al. The usefulness of endoscopic ultrasound-guided fine-needle aspiration for the diagnosis of pancreatic neuroendocrine tumors based on the World Health Organization classification. Scand J Gastroenterol 2014; 49: 1367-1374
- 22 Fujimori N, Osoegawa T, Lee L. et al. Efficacy of endoscopic ultrasonography and endoscopic ultrasonography-guided fine-needle aspiration for the diagnosis and grading of pancreatic neuroendocrine tumors. Scand J Gastroenterol 2016; 51: 245-252
- 23 Arra DASM, Ribeiro HSC, Henklain G. et al. Surgery or active surveillance for pNETs < 2 cm: preliminary results from a single center Brazilian cohort. J Surg Oncol 2022; 126: 168-174
- 24 Perinel J, Nappo G, Zerbi A. et al. Sporadic nonfunctional pancreatic neuroendocrine tumors: risk of lymph node metastases and aggressiveness according to tumor size: a multicenter international study. Surgery 2022; 172: 975-981